cro.directory
← Compare landing

GemPharmatech vs NorthernBio

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/gempharmatech/northernbiolab

CategoryGemPharmatechNorthernBio
Listed sitecrocro
SummaryGemPharmatech develops and supplies genetically engineered mouse models (GEMMs) and preclinical research services using CRISPR/Cas9 and gene-editing technologies, with a library of 25,000+ mouse strains including KO/cKO, humanized, and immunodeficient models.Michigan-based preclinical CRO specializing in GLP-compliant in vivo safety assessment, targeted drug delivery, molecular biology, and ligand binding bioanalysis across neuroscience, ophthalmology, cardiovascular, metabolic, and rare disease indications.
Services
  • Specialized & Large-Animal Models
  • In Vivo PK / PD Studies
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • In Vitro Pharmacology
  • Preclinical In Vitro Studies
  • Target Identification & Validation
  • GLP Toxicology
  • In Vivo PK / PD Studies
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • Ligand-Binding Bioanalysis (Large Molecule)
  • Bioanalysis
  • Specialized & Large-Animal Models
Modalities
  • Biologics (Monoclonal Antibodies)
Data not yet provided.
Indications
  • Oncology
  • Immunology
  • Neurology
  • Metabolic
  • Cardiovascular
  • Infectious Disease
  • Rare Disease
  • Neurology
  • Ophthalmology
  • Cardiovascular
  • Metabolic
  • Rare Disease
Locations
  • Headquarters, Jiangsu, China
  • Muskegon, Muskegon, Michigan, United States
  • Norton Shores, Norton Shores, Michigan, United States
  • Portage, Portage, Michigan, United States
CertificationsData not yet provided.
  • FDA · Identifier: 21 CFR Part 58
  • FDA · Identifier: 21 CFR Part 11
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.